{'fraction_non_alphanumeric': 0.028384279475982533, 'fraction_numerical': 0.017467248908296942, 'mean_word_length': 5.6521739130434785, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
ICR expands CanSAR drug discovery platform.

The UK's Institute of Cancer Research, London has broadened its CanSAR knowledgebase, a cancer drug-discovery platform that integrates genomic, chemical, and pharmacologic data. The newly released CanSAR 2.0 adds more prediction methodologies and holds data on more than 8 million experimentally derived measurements, nearly 1 million biologically active chemical compounds, and more than 1,000 cancer cell lines.